Skip to main content


Figure 4 | Biology Direct

Figure 4

From: Kinetics of the viral cycle influence pharmacodynamics of antiretroviral therapy

Figure 4

Simulations that demonstrate how altering viral life cycle kinetics can improve drug efficacy. Log-log concentration-response curves for (A) a hypothetical drug #1 and drug #2 where IC501 > IC502 but m1 = 1 and m2 = 3, showing how decreasing IC50 in drug #1 changes the concentration regime where each drug may have greater antiviral activity, and (B) with the example of how abacavir antiviral activity (blue concentration-response curve for IC50 = 0.0344 μM, red concentration-response curve for IC50 = 0.0172 μM) relative to nelfinavir (black concentration-response curve) may be improved by decreasing IC50. Light blue bar above indicates the clinical concentration range of abacavir and orange bar indicates clinical concentration range of nelfinavir.

Back to article page